Dacron vs Dardik for Fem-Pop Bypass
DaDa
Heparin Bonded and Collagen Coated Polyester or Human Umbilical Vein for Femoropopliteal Bypass: a Prospective Randomised Multicentre Trial.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Clinical trial for the comparison of long-term patency of heparin-bonded Dacron and human umbilical vein vascular prostheses in above-knee femoro-popliteal bypass surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 1996
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1996
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 30, 2007
CompletedFirst Posted
Study publicly available on registry
August 31, 2007
CompletedAugust 31, 2007
August 1, 2007
August 30, 2007
August 30, 2007
Conditions
Outcome Measures
Primary Outcomes (1)
Primary and primary-assisted bypass patency
1 - 5 yrs
Secondary Outcomes (1)
Secondary bypass patency
1 - 5 yrs
Study Arms (2)
Dacron
ACTIVE COMPARATORPatients receiving polyester above-knee femoro-popliteal bypass
HUV
ACTIVE COMPARATORpatients receiving HUV femoro-popliteal bypass
Interventions
Eligibility Criteria
You may qualify if:
- age 31 to 89
- intermittent claudication
- ABI below 0.8
You may not qualify if:
- non elective surgery
- life expectancy below 2 yrs
- contraindication for anticoagulant therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud UMCN, Dept Vascular Surgery
Nijmegen, 6500 HB, Netherlands
Related Publications (3)
Scharn DM, Oyen WJ, Klemm PL, Verhofstad AA, van der Vliet JA. Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts. J Surg Res. 2006 Aug;134(2):182-9. doi: 10.1016/j.jss.2006.01.025. Epub 2006 Mar 20.
PMID: 16542682BACKGROUNDScharn DM, Oyen WJ, Klemm PL, Wijnen MH, vanderVliet JA. Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model. Cardiovasc Surg. 2002 Dec;10(6):566-9. doi: 10.1016/s0967-2109(02)00077-7.
PMID: 12453688BACKGROUNDDirven M, Scharn DM, Blankensteijn JD, van der Vliet JA. Preservation for future use of the autologous saphenous vein during femoro-popliteal bypass surgery is inexpedient. Eur J Vasc Endovasc Surg. 2008 Oct;36(4):420-3. doi: 10.1016/j.ejvs.2008.06.012.
PMID: 18675557DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J. Adam van der Vliet, MD, PhD
Radboud University Medical Center Nijmegen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 30, 2007
First Posted
August 31, 2007
Study Start
January 1, 1996
Study Completion
April 1, 2007
Last Updated
August 31, 2007
Record last verified: 2007-08